down arrow

Vcanbio Cell & Gene Engineering Corp., Ltd.

  • Market Cap: Mid Cap
  • Industry: Miscellaneous
  • ISIN: CNE000000545
  • SHG: 600645
CNY
19.29
0.24 (1.26%)

Sep 22

SHG

 View all stocks in this country
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Vcanbio Cell & Gene Engineering Corp., Ltd.

Why is Vcanbio Cell & Gene Engineering Corp., Ltd. ?

1
Poor Management Efficiency with a low ROCE of 4.85%
  • The company has been able to generate a Return on Capital Employed (avg) of 4.85% signifying low profitability per unit of total capital (equity and debt)
2
The company is Net-Debt Free
  • Poor long term growth as Net Sales has grown by an annual rate of 0.22% and Operating profit at 3.97% over the last 5 years
  • The company is Net-Debt Free
  • The company has been able to generate a Return on Equity (avg) of 2.55% signifying low profitability per unit of shareholders funds
3
Poor long term growth as Net Sales has grown by an annual rate of 0.22% and Operating profit at 3.97% over the last 5 years
4
Positive results in Jun 26
  • OPERATING CASH FLOW(Y) Highest at CNY 334.14 MM
  • ROCE(HY) Highest at 3.17%
  • DEBT-EQUITY RATIO (HY) Lowest at -46.77 %
5
With ROE of 2.59%, it has a attractive valuation with a 2.10 Price to Book Value
  • Over the past year, while the stock has generated a return of -22.02%, its profits have fallen by -6.7%
6
Underperformed the market in the last 1 year
  • Even though the market (China Shanghai Composite) has generated returns of 3.40% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -22.02% returns
stock-recommendationReal-Time Research Report

Verdict Report

How much should you hold?

  1. Overall Portfolio exposure to Vcanbio Cell & Gene Engineering Corp., Ltd. should be less than 10%
  2. Overall Portfolio exposure to Miscellaneous should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Miscellaneous)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Vcanbio Cell & Gene Engineering Corp., Ltd. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Vcanbio Cell & Gene Engineering Corp., Ltd.
-21.78%
0.30
45.71%
China Shanghai Composite
3.23%
0.23
14.72%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
0.22%
EBIT Growth (5y)
3.97%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.42
Sales to Capital Employed (avg)
0.41
Tax Ratio
38.21%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
6.34%
ROE (avg)
2.55%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
81
Industry P/E
Price to Book Value
2.10
EV to EBIT
40.92
EV to EBITDA
23.15
EV to Capital Employed
3.05
EV to Sales
4.32
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
7.44%
ROE (Latest)
2.59%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

9What is working for the Company
OPERATING CASH FLOW(Y)

Highest at CNY 334.14 MM

ROCE(HY)

Highest at 3.17%

DEBT-EQUITY RATIO (HY)

Lowest at -46.77 %

RAW MATERIAL COST(Y)

Fallen by -4.15% (YoY

CASH AND EQV(HY)

Highest at CNY 3,552.63 MM

-2What is not working for the Company
INVENTORY TURNOVER RATIO(HY)

Lowest at 2.11 times

DEBTORS TURNOVER RATIO(HY)

Lowest at 2.19 times

Here's what is working for Vcanbio Cell & Gene Engineering Corp., Ltd.

Operating Cash Flow
Highest at CNY 334.14 MM and Grown
In each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Debt-Equity Ratio
Lowest at -46.77 % and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Cash and Eqv
Highest at CNY 3,552.63 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Raw Material Cost
Fallen by -4.15% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Vcanbio Cell & Gene Engineering Corp., Ltd.

Inventory Turnover Ratio
Lowest at 2.11 times
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Debtors Turnover Ratio
Lowest at 2.19 times
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Footer loading